Valuation: Novo Integrated Sciences, Inc.

Market Cap 19.73K 17.35K 16.41K 14.88K 27.95K 1.89M 28.11K 196K 75.88K 966K 74.07K 72.47K 3.11M P/E 2023
-1.08x
P/E 2024 -0.35x
Enterprise Value 5.16M 4.53M 4.29M 3.89M 7.3M 495M 7.35M 51.34M 19.83M 253M 19.36M 18.94M 811M EV / Sales 2023
2.07x
EV / Sales 2024 0.84x
Free-Float
93.41%
Yield 2023 *
-
Yield 2024 -
Current month+550.00%
1 month+11.43%
3 months+387.50%
6 months+550.00%
Current year+44.44%
1 month 0
Extreme 0.0006
0
Current year 0
Extreme 0.0005
0.03
1 year 0
Extreme 0.0001
0.06
3 years 0
Extreme 0.0001
5.29
5 years 0
Extreme 0.0001
33.2
10 years 0
Extreme 0.0001
299
Manager TitleAgeSince
Director of Finance/CFO 40 2023-07-06
Chief Executive Officer 67 2017-05-08
Director TitleAgeSince
Director/Board Member 67 2014-08-12
Chairman 58 2018-10-17
Director/Board Member 52 2021-01-25
Date Insider Type Main position Quantity % Market Cap. Importance
5/31/23 Other

Chief Operating Officer

2,000,000 1.3864%
8/9/22 Free

Director

39,480 0.1273%
4/19/22 Buy

Director

10,000 0.0348%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-51.85%-99.81% 76.95K
-1.44%+0.29%+16.25%+25.45% 114B
-0.69%+1.56%+2.77%+72.59% 94.31B
+1.27%+0.50%-0.43%+58.97% 29.62B
+0.55%-2.96%+25.83%+92.64% 26.08B
0.00%-3.04%-14.49%-5.67% 20.79B
-0.69%-1.16%+28.20%+283.03% 20.91B
+0.21%-1.71%-11.42%+50.24% 15.68B
+1.71%+4.63%-7.30%-1.82% 12.02B
-0.22%-2.34%+36.36%+84.91% 11.38B
Average +0.22%-0.31%+2.39%+56.05% 34.48B
Weighted average by Cap. -0.11%+0.29%+9.31%+62.19%

Financials

2023 2024
Net sales 12.57M 11.06M 10.46M 9.48M 17.81M 1.21B 17.91M 125M 48.35M 616M 47.2M 46.18M 1.98B 13.29M 11.69M 11.06M 10.03M 18.83M 1.28B 18.94M 132M 51.13M 651M 49.91M 48.83M 2.09B
Net income -13.21M -11.62M -10.99M -9.97M -18.72M -1.27B -18.83M -132M -50.82M -647M -49.61M -48.54M -2.08B -16.17M -14.22M -13.45M -12.2M -22.9M -1.55B -23.04M -161M -62.17M -792M -60.7M -59.38M -2.54B
Net Debt 4.06M 3.57M 3.37M 3.06M 5.75M 389M 5.78M 40.38M 15.6M 199M 15.23M 14.9M 638M 5.14M 4.52M 4.27M 3.87M 7.28M 493M 7.32M 51.14M 19.75M 252M 19.28M 18.86M 808M
Logo Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. owns Canadian and United States subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, diagnostic solutions, personalized product offerings, and rehabilitative science. It operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
Employees
190
Date Price Change Volume
26-09-28 US$0.003900 0.00% 1,104
  1. Stock Market
  2. Stocks
  3. NVOS Stock